March 09, 2020
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy
Media
March 04, 2020
Fusion Pharmaceuticals Announces Appointment of Steven Gannon to Board of Directors
March 03, 2020
GenSight Biologics announces presentation of bilateral visual recovery from GS010 (LUMEVOQ™) Phase III trials at the 46th annual meeting of NANOS
March 03, 2020
Targovax announces completed enrollment in the ONCOS-102 trial in anti-PD1 refractory melanoma
March 03, 2020
Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2019 results, Wednesday 11 March
March 02, 2020
Oncopeptides strengthens its organization by appointing Karolina Vilval as General Counsel
February 28, 2020
Year-end report 2019
February 27, 2020
Strongbridge Biopharma plc to Present at the Cowen and Company 40th Annual Healthcare Conference
February 27, 2020
Nordic Nanovector ASA – Results for the Fourth Quarter and Full Year 2019
February 26, 2020
Nordic Nanovector Appoints Dr Lars Nieba as interim Chief Executive Officer